ARTICLE | Clinical News
Reolysin cancer data
November 15, 2010 8:00 AM UTC
A histological analysis of 6 evaluable patients treated with IV Reolysin for 5 consecutive days given at 1-3 weeks prior to surgical resection of liver metastases in the open-label, U.K. REO 013 trial...